Evidence map›Paper›PMID 40419690›Full record

ArticleSocial psychiatry and psychiatric epidemiology2025

The RECAPACITA PROJECT: comparative study of the clinical, neuropsychological, and functional profile of people with severe mental disorder and partial and total capacity modification.

Silvia Marcó-García, Georgina Guilera, Marta Ferrer-Quintero, Susana Ochoa, Gemma Escuder-Romeva, Elena Rubio-Abadal, Arantxa Martínez-Mondejar, Núria Del Cacho, Vanessa Montalbán-Roca, Ana Escanilla-Casal and 2 more

Abstract readComparative Study
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Silvia Marcó-GarcíaParc Sanitari Sant Joan de Déu, Barcelona, Spain. silvia.marco@sjd.es.
Georgina GuileraDepartment of Social Psychology and Quantitative Psychology, Faculty of Psychology, University of Barcelona, 08035, Barcelona, Spain.
Marta Ferrer-QuinteroParc Sanitari Sant Joan de Déu, Barcelona, Spain.
Susana OchoaParc Sanitari Sant Joan de Déu, Barcelona, Spain.
Gemma Escuder-RomevaParc Sanitari Sant Joan de Déu, Barcelona, Spain.
Elena Rubio-AbadalParc Sanitari Sant Joan de Déu, Barcelona, Spain.
Arantxa Martínez-MondejarParc Sanitari Sant Joan de Déu, Barcelona, Spain.
Núria Del CachoParc Sanitari Sant Joan de Déu, Barcelona, Spain.
Vanessa Montalbán-RocaGermà Tomàs Canet Foundation, Sant Boi de Llobregat, Spain.
Ana Escanilla-CasalParc Sanitari Sant Joan de Déu, Barcelona, Spain.
Sol Balsells-MejíaResearch Promotion and Management Department, Statistical Support, Hospital Sant Joan de Déu (HSJD), Barcelona, Spain.
Elena Huerta-RamosParc Sanitari Sant Joan de Déu, Barcelona, Spain. mariaelena.huerta@sjd.es.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2019FI_B 00267Instituto de Salud Carlos III PI17/00113
6 · The paper itself

Abstract

backgroundEvaluating the decision-making capacity of individuals with Severe Mental Disorder (SMD) is essential for compliance with the 2006 Convention on the Rights of People with Disabilities. In Spain, capacity was historically determined through judicial procedures, resulting in partial or total capacity modification (CM). The abolition of this procedure in 2021 has left a gap in addressing the needs of this population, creating challenges under the new legal framework.

aimThe RECAPACITA project studied the clinical, neuropsychological, and functional profiles of individuals with SMD and CM, focusing on differences between partial (pCM) and total (tCM) modifications.

methodsA cross-sectional study was conducted with 77 adult patients with SMD and CM (47 tCM, 30 pCM) from the Parc Sanitari Sant Joan de Déu mental health network (Spain). Sociodemographic, clinical, functional, and neuropsychological data were collected, along with an independent assessment of mental capacity.

resultsAround 87% of sample had a schizophrenia spectrum disorder; pCM patients presented more substance-related and personality disorders as a secondary diagnosis. While no statistically significant differences were observed between groups, clinically, tCM group presents greater clinical alteration, lower insight, sustained attention, coding capacity, processing speed and resistance to interference compared to pCM group. tCM group had worse social functioning, and lower scores in reasoning and appreciation when assessing mental capacity.

conclusionsIndividuals with tCM show greater clinical impairment and higher support needs compared to those with pCM. With the practical and legal abolition of tCM, it is essential to ensure that these individuals' persistent challenges are adequately addressed, as their needs remain significant despite the disappearance of this legal category.

Indexed as

Decision MakingMental CompetencyMental DisordersSchizophreniaAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeuropsychological TestsSeverity of Illness IndexSpainDecision-making capacityLegislationMental capacityMental diseaseSchizophrenia

Identifiers

PMID40419690
PMCPMC12594664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.